Cell Expansion Market: Industry Analysis and Forecast (2021-2027) by Product, Cell Type, Application, End-user, and Region

By 2027, Cell Expansion Market is expected to reach US$ 39.6 billion. The report analyses Cell Expansion Market dynamics and market trends.

Cell Expansion Market Overview:

Cell expansion necessitates the production of new cell wall material as well as the gradual relaxation of the cell wall to allow it to stretch and expand in size. The so-called expansion family of cell-wall-associated proteins plays a crucial role in this process. Expansions promote wall extensibility by disrupting non-covalent connections between wall polysaccharides, allowing them to slide around about one another. Cell Expansion Market To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2015 to forecast the market through 2026. 2020 is considered a base year however 2020's numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.

Cell Expansion Market Dynamics:

Cell Expansion Market size was valued at US$ 21.3 Bn. in 2020 and the revenue is expected to grow at 8.6% through 2021 to 2027, reaching nearly US$ 39.6 Bn. One of the market drivers is the increased use of automated solutions in cell expansion applications. Automated methods reduce the amount of time and money needed to make Cell Therapy Products (CTP), gene treatments, and other biologics, resulting in more stable and dependable procedures. To meet the enormous increase in global demand for these therapeutic solutions, key firms involved in CTP development are increasing their product lines. Lonza, for example, launched a full CellBio Services portfolio in March 2019, which includes cell-line expansion and banking services. This solution is intended to meet the needs of research applications, hence accelerating market income generation. In CTP manufacturing, the paradigm change toward Single-Use Systems (SUS) offers significant productivity benefits. Cross-contamination and culture contamination caused by improper sterilization is no longer an issue with SUS. SUS also enables the fabrication of CTP with high cell densities while also providing long-term cost benefits. As a result, increased adoption of SUS accelerates the development of CTP, boosting the market growth. In the life sciences field, cellular therapies are continually gaining favor. The market is being driven by an increase in funding from private and government organizations, as well as activities undertaken by them to support the development of cellular therapies. The International Society for Stem Cell Research is interested in locating stem cell-related funding possibilities across a variety of scientific research applications.

Cell Expansion Market Segment Analysis:

The Consumables segment is estimated to grab larger market attention in the Cell Expansion Market. In 2020, consumables were the most popular product segment, accounting for xx% of total sales. Throughout the forecast years, it is expected to maintain its leading position. The substantial revenue share of this category is due to the availability of a wide range of commercial medium and reagent items targeted to certain types of cells. Furthermore, these products are handy, ready-to-use, and serum-free formulations are available. Automation in bioreactors and other expansion platforms to increase the efficiency of culturing procedures is predicted to drive the quickest CAGR in the instrument’s category over the forecast period. The introduction of automated platforms has standardized the process and made process tracking easier while reducing hands-on time, allowing trained workers to make better use of their time. The Mammalian cells segment is supplementing the growth of the Cell Expansion Market. Since these culture systems are highly preferred in the manufacturing of complex protein therapies, the mammalian cells segment held the biggest revenue share of xx% in 2020 and will continue to do so during the projected period. This is because post-translational changes in humans are pharmacokinetically and functionally relevant to these systems. As a result, these culture systems are used to create the majority of biopharmaceuticals, such as monoclonal antibodies, particular interferons, thrombolytics, and numerous therapeutic enzymes. Although differentiated human cells fulfill a specialized job in the body, they accounted for a significant revenue share. Differentiated cells, such as fibroblasts, have become increasingly important in cutaneous wound healing and skin bioengineering, allowing segments to grow faster. Furthermore, the use of 3D Gingival Fibroblast (GF) toroids as a practical and easy in vitro biomaterial testing method has increased. The biopharmaceutical segment is enhancing the growth of the Cell Expansion Market. In 2020, the biopharmaceutical firms section had the highest share of xx% and is expected to increase at a significant rate in the future. One of the primary factors leading to the increasing share of biopharmaceutical businesses is the expanding scope of cell-based medicines in the healthcare industry. Cell-based therapies, for example, have exploded in popularity in regenerative medicine, because of ongoing advancements in injectable cell delivery systems for a variety of clinical applications. Acquisitions are also being made by pharmaceutical and biopharmaceutical businesses to increase their product offering. Sartorius AG, for example, struck an agreement in December 2019 to buy 50% of Biological Industries, an Israeli cell culture media company. Sartorius' cell culture medium portfolio was increased as a result of this acquisition, particularly for cellular and gene treatments, regenerative medicine, and other advanced medicines. Cell Expansion Market

Cell Expansion Market Regional Insights:

North America is ruling the growth of the regional Cell Expansion market in the forecast period. In 2020, North America had the highest share of xx%. Due to an increase in government financing initiatives, which has accelerated the synthesis of stem cells and the development of regenerative medicine and cellular therapy products, the region will maintain its leadership position in the next years. As a result, demand for cell expansion platforms in this region is on the rise. For instance, the FDA and the Medical Technology Enterprise Consortium (MTEC) jointly provided USD 5.3 million to the Southwest Research Institute (SwRI) in October 2019. (U.S.). This funding was used by the SwRI to proliferate cells to develop individualized regenerative medicine. Such investments help the region generate more revenue. Due to increased efforts by various local pharmaceutical and biotechnology businesses to develop and commercialize their cellular therapies, Asia Pacific is predicted to grow at the quickest rate throughout the projection period. In July 2019, Stempeutics Research Pvt. Ltd., an Indian business, formed an association with Kemwell Biopharma for the development of Stempeucel, a stem cell-based medicine. Small and mid-sized businesses are likely to benefit from such arrangements, which are projected to increase product sales. Cell Expansion MarketThe objective of the report is to present a comprehensive analysis of the Cell Expansion Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Cell Expansion Market dynamics, structure by analyzing the market segments and projecting the Cell Expansion Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Cell Expansion Market make the report investor’s guide.

Cell Expansion Market Scope: Inquire before buying

Cell Expansion Market

Cell Expansion Market, by Region

• North America o US o Canada o Mexico • Europe o U.K o France o Germany o Italy o Spain o Sweden o CIS Countries o Rest of Europe • Asia Pacific o China o India o Japan o South Korea o Australia o ASEAN o Rest of Asia Pacific • The Middle East and Africa o South Africa o GCC Countries o Egypt o Nigeria o Rest of ME&A • South America o Brazil o Argentina o Rest of South America

Cell Expansion Market Key Players

Thermo Fisher Scientific, Inc. (US) • Danaher (US) • Becton, Dickinson and Company (US) • Lonza (Switzerland) • Corning, Inc. (US) • Merck KGaA (Germany) • Sartorius Stedim Biotech (France) • Getinge AB (Sweden) Terumo Corporation (Japan) • Miltenyi Biotec (Germany) • Lonza Group AG • PromoCell GmbH • Danaher Corporation • HiMedia Laboratories. • Terumo Bct, Inc. • Sartorius AG • Takara Bio, Inc. • Trinova Biochem GmbH • upcyte technologies GmbH FAQs: 1. What is the Cell Expansion market value in 2020? Ans: The Cell Expansion market value in 2020 was estimated as 21.3 Billion USD. 2. Which Cell Type segment is likely to dominate the Cell Expansion market growth? Ans: The Mammalian cells segment held the largest revenue share of 58.5% in 2019 and will remain dominant during the forecast period as these culture systems are highly preferred in the production of complex protein therapeutics. 3. Which Segment is expected to dominate the Cell Expansion market during the forecast period? Ans: North America accounted for the largest share of 43.1% in 2019. The region will retain its leading position over the coming years due to a rise in funding initiatives by the government agencies, which has accelerated the manufacture of stem cells and the development of regenerative medicine and cellular therapy products. 4. What are the factors driving the Cell Expansion market? Ans: Some of the major drivers of the cell expansion market include Increasing incidence of chronic diseases, government investments for cell-based research, growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities. 5. Who are the key players in the Cell Expansion market? Ans: Some key players operating in the Cell Expansion market Thermo Fisher Scientific, Inc.; GE Healthcare; Corning, Inc.; STEMCELL Technologies, Inc.; Merck KGaA; Miltenyi Biotec; Becton, Dickinson, and Company; Terumo Bct, Inc.; Sartorius AG; Takara Bio, Inc.; Trinova Biochem GmbH; upcyte technologies GmbH
1. Global Cell Expansion Market: Research Methodology 2. Global Cell Expansion Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Cell Expansion Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Cell Expansion Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Cell Expansion Market Segmentation 4.1 Global Cell Expansion Market, by Product (2020-2027) • Consumables o Reagents, Media, & Serum o Other Consumables • Culture Flasks and Accessories o Tissue Culture Flasks o Bioreactor Accessories o Other Culture Flasks and Accessories • Instruments o Automated Cell Expansion Systems o Cell Counters o Centrifuges o Bioreactors • Other Instruments 4.2 Global Cell Expansion Market, by Cell Type (2020-2027) • Mammalian  Human o Stem Cells (SCs)  Adult SCs  Embryonic SCs  Induced Pluripotent SCs o Differentiated Cells  Animal • Microbial • Others 4.3 Global Cell Expansion Market, By Application (2020-2027) • Biopharmaceuticals • Tissue Culture & Engineering • Vaccine Production • Drug Development • Gene Therapy • Cancer Research • Stem Cell Research • Others 4.4 Global Cell Expansion Market, by End-User (2020-2027) • Biopharmaceutical & Biotechnology Companies • Research Institutes • Cell Banks • Others 5. North America Cell Expansion Market (2020-2027) 5.1 North America Cell Expansion Market, by Product (2020-2027) • Consumables o Reagents, Media, & Serum o Other Consumables • Culture Flasks and Accessories o Tissue Culture Flasks o Bioreactor Accessories o Other Culture Flasks and Accessories • Instruments o Automated Cell Expansion Systems o Cell Counters o Centrifuges o Bioreactors • Other Instruments 5.2 North America Cell Expansion Market, by Cell Type (2020-2027) • Mammalian  Human o Stem Cells (SCs)  Adult SCs  Embryonic SCs  Induced Pluripotent SCs o Differentiated Cells  Animal • Microbial • Others 5.3 North America Cell Expansion Market, By Application (2020-2027) • Biopharmaceuticals • Tissue Culture & Engineering • Vaccine Production • Drug Development • Gene Therapy • Cancer Research • Stem Cell Research • Others 5.4 North America Cell Expansion Market, by End-User (2020-2027) • Biopharmaceutical & Biotechnology Companies • Research Institutes • Cell Banks • Others 5.5 North America Cell Expansion Market, by Country (2020-2027) • US • Canada • Mexico 6 Asia Pacific Cell Expansion Market (2020-2027) 6.1. Asia Pacific Cell Expansion Market, by Product (2020-2027) 6.2. Asia Pacific Cell Expansion Market, By Cell Type (2020-2027) 6.3. Asia Pacific Cell Expansion Market, By Application (2020-2027) 6.4. Asia Pacific Cell Expansion Market, by End-User (2020-2027) 6.5. Asia Pacific Cell Expansion Market, by Country (2020-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7 Middle East and Africa Cell Expansion Market (2020-2027) 7. 1 Middle East and Africa Cell Expansion Market, by Product (2020-2027) 7.2. Middle East and Africa Cell Expansion Market, by Cell Type (2020-2027) 7.3. Middle East and Africa Cell Expansion Market, By Application (2020-2027) 7.4. Middle East and Africa Cell Expansion Market, by End-User (2020-2027) 7.5. Middle East and Africa Cell Expansion Market, by Country (2020-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8 Latin America Cell Expansion Market (2020-2027) 8.1. Latin America Cell Expansion Market, by Product (2020-2027) 8.2. Latin America Cell Expansion Market, by Cell Type (2020-2027) 8.3. Latin America Cell Expansion Market, By Application (2020-2027) 8.4. Latin America Cell Expansion Market, by End-User (2020-2027) 8.5. Latin America Cell Expansion Market, by Country (2020-2027) • Brazil • Argentina • Rest of Latin America 9 European Cell Expansion Market (2020-2027) 9.1. European Cell Expansion Market, by Product (2020-2027) 9.2. European Cell Expansion Market, by Cell Type (2020-2027) 21.3. European Cell Expansion Market, By Application (2020-2027) 9.4. European Cell Expansion Market, by End-User (2020-2027) 9.5. European Cell Expansion Market, by Country (2020-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10 Company Profile: Key players 10.1. Merck KGaA 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Geographic Footprint 10.1.4. Grade Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Thermo Fisher Scientific, Inc. (US) 10.3. Danaher (US) 10.4. Becton, Dickinson and Company (US) 10.5. Lonza (Switzerland) 10.6. Corning, Inc. (US) 10.7. Merck KGaA (Germany) 10.8. Sartorius Stedim Biotech (France) 10.9. Getinge AB (Sweden) Terumo Corporation (Japan) 10.10. Miltenyi Biotec (Germany) 10.11. Lonza Group AG 10.12. PromoCell GmbH 10.13. Danaher Corporation 10.14. HiMedia Laboratories. 10.15. Terumo Bct, Inc. 10.16. Sartorius AG 10.17. Takara Bio, Inc. 10.18. Trinova Biochem GmbH 10.19. upcyte technologies GmbH

About This Report

Report ID311
Category Healthcare
Published DateNov 2019
Updated DateNov 2021
Contact Us